Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Point of Care - Triage and Treatment for Cervical Pre-cancer

NCT: NCT07461818 · RECRUITING

NCT IDNCT07461818
StatusRECRUITING
Start Date2026-01-01
Completion2029-08
SponsorBasic Health International, Inc. (OTHER)
First posted
Last updated

Brief Summary

This study evaluates a modified two-probe thermal ablation protocol using the IRIS™ device and retrospectively assesses an AI-based Automated Visual Evaluation (AVE) triage algorithm among HPV-positive women in El Salvador. The primary objective is to estimate 1-year cure rates of CIN2+ following treatment. A secondary objective is to evaluate the diagnostic performance of AVE compared with histopathology.

Frequently Asked Questions

What is Point of Care - Triage and Treatment for Cervical Pre-cancer?

Point of Care - Triage and Treatment for Cervical Pre-cancer is a clinical trial registered under NCT07461818. Current status: RECRUITING.

What is the status of NCT07461818?

The current status of NCT07461818 (Point of Care - Triage and Treatment for Cervical Pre-cancer) is: RECRUITING.

When did Point of Care - Triage and Treatment for Cervical Pre-cancer start?

Point of Care - Triage and Treatment for Cervical Pre-cancer started on 2026-01-01.

Related Devices

K200061HEATfx Microwave Ablation System, HEATfx Microwave Ablation System Cart, HEATfx 2.1 Needle, HEATfx 2.1 S Needle, Multi-Point Thermal Sensor (MTS)Galil Medical, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑